The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Reliability & Utility of Serological Antibody Tests in COVID-19

The Reliability & Utility of Serological Antibody Tests in COVID-19

September 11, 2020 • By Ruth Jessen Hickman, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Corona Borealis Studio / shutterstock.comSerological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown.

You Might Also Like
  • Serological Antibody Tests in COVID-19: Test Reliability and Utility
  • After COVID-19-Associated MIS-C, Immune Changes Resolve
  • Jury Out on Immunomodulatory Therapy for Kids with Severe COVID-19
Explore This Issue
September 2020
Also By This Author
  • Race As a Risk Factor for Sjögrens Syndrome

Although such testing may ultimately be used to help determine immune status, infectious disease specialists caution that such use is premature at this time. The plethora of tests currently available—many not properly validated—add to clinicians’ confusion about their appropriate use and interpretation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Antibodies & the Immune Response

Antibodies are protective proteins produced and secreted by B cells and plasma cells in response to a foreign antigen. Among other functions, they attach to specific foreign antigens and neutralize them, facilitate phagocytosis and activate the complement system.

Individual antibodies recognize specific antigens via their variable binding sites. This phenomenon accounts for the fact that an antibody for mumps is unlikely to recognize and bind to the measles virus, due to differences in nucleic acid sequence. Cross-reactivity of antibodies may sometimes occur, however, particularly for viruses in the same family, which may share homologous sequences. Thus, a particular antibody may not differentiate SARS-CoV-2 from one of the corona­viruses that can cause common colds.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

This helps account for some cases of false positivity in serological testing for anti­bodies. In COVID-19, some false positive antibody testing is likely to occur from individuals’ existing antibodies to other coronaviruses that are extremely common in the population.

Based on their overall structure and roles, human antibodies are classified into five different isotypes. During acute infection, B cells typically first produce antibodies of the IgM isotype, but its levels may fall off quickly. IgG antibodies, largely responsible for long-term immunity after infection or vaccination, usually arrive a little later. Compared with IgM, IgG binds with higher specificity, and it may be detected for months or years in the blood.1

The FDA has announced it will take action against tests falsely advertised as FDA authorized that have not been granted EUA status, & it has issued a limited number of cease & desist letters.

Antibodies can also be characterized by whether they are neutralizing or non-neutralizing.

In antibody-mediated viral neutralization, antibodies in cell culture may bind to specific viral domains and prevent entry into the cell. This is the type of antibody interaction desired for long-term immune protection. Other positive antibody responses may help engage other parts of the immune system, such as encouraging phagocytosis.2

Only a small subset of the antibodies formed against the virus will be of the neutralizing type: Antibodies may have other effects. Some antibodies produced have neither positive nor negative effects on a given infection. Others may upregulate pro-inflammatory cytokines, potentially resulting in immunopathology. Even more concerning is a potential problem called antibody-dependent enhancement of infection. In this scenario, which has been documented in other viruses such as dengue, antibodies may bind to the virus and facilitate viral entry into cells.2

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions Tagged With: Antibodies, COVID-19, TestingIssue: September 2020

You Might Also Like:
  • Serological Antibody Tests in COVID-19: Test Reliability and Utility
  • After COVID-19-Associated MIS-C, Immune Changes Resolve
  • Jury Out on Immunomodulatory Therapy for Kids with Severe COVID-19
  • ACR Releases COVID-19 Clinical Guidance for Pediatric Patients

About Ruth Jessen Hickman, MD

Ruth Jessen Hickman, MD, was born and raised in eastern Kentucky, where she first cultivated her love of literature, writing and personal narratives. She attended Kenyon college, where she received a Bachelor of Arts in philosophy, summa cum laude. She worked with individuals with psychiatric conditions and later in a neuroscience lab at the University of Illinois, Chicago, before graduating from Indiana University Medical School in 2011. Instead of pursuing clinical medicine, Ruth opted to build on her strength of clearly explaining medical topics though a career as a freelance medical writer, writing both for lay people and for health professionals. She writes across the biomedical sciences, but holds strong interests in rheumatology, neurology, autoimmune diseases, genetics, and the intersection of broader social, cultural and emotional contexts with biomedical topics. Ruth now lives in Bloomington, Ind., with her husband, son and cat. She can be contacted via her website at ruthjessenhickman.com.

View more by this author»

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.